Breier, Alan <br/><br/>
Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.  [electronic resource] 

 -  The American journal of psychiatry  Oct 2005 
 - 1879-87 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0002-953X 
<br/><br/><label>Standard No.: </label>10.1176/appi.ajp.162.10.1879  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age of Onset<br/>Antipsychotic Agents--adverse effects<br/>Basal Ganglia Diseases--chemically induced<br/>Benzodiazepines--adverse effects<br/>Blood Glucose--analysis<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Fasting<br/>Female<br/>Humans<br/>Lipids--blood<br/>Male<br/>Olanzapine<br/>Piperazines--adverse effects<br/>Psychiatric Status Rating Scales<br/>Quality of Life<br/>Schizophrenia--blood<br/>Schizophrenic Psychology<br/>Severity of Illness Index<br/>Thiazoles--adverse effects<br/>Treatment Outcome